S&P 500   2,966.15 (-0.14%)
DOW   26,787.36 (-0.11%)
QQQ   191.09 (-0.01%)
AAPL   235.87 (-0.14%)
FB   183.28 (-0.49%)
MSFT   139.55 (-0.09%)
AMZN   1,736.43 (+0.26%)
CGC   18.86 (-2.93%)
NVDA   186.53 (+0.29%)
BABA   171.16 (-1.03%)
GE   8.72 (-0.91%)
T   37.47 (-0.29%)
F   8.82 (+0.46%)
ACB   3.51 (-4.62%)
S&P 500   2,966.15 (-0.14%)
DOW   26,787.36 (-0.11%)
QQQ   191.09 (-0.01%)
AAPL   235.87 (-0.14%)
FB   183.28 (-0.49%)
MSFT   139.55 (-0.09%)
AMZN   1,736.43 (+0.26%)
CGC   18.86 (-2.93%)
NVDA   186.53 (+0.29%)
BABA   171.16 (-1.03%)
GE   8.72 (-0.91%)
T   37.47 (-0.29%)
F   8.82 (+0.46%)
ACB   3.51 (-4.62%)
Log in

AzurRx BioPharma Insider Trading Activity (NASDAQ:AZRX)

$0.45
-0.04 (-8.16 %)
(As of 10/14/2019 04:00 PM ET)
Today's Range
$0.42
Now: $0.45
$0.50
50-Day Range
$0.47
MA: $0.89
$1.23
52-Week Range
$0.46
Now: $0.45
$3.10
Volume133,078 shs
Average Volume527,432 shs
Market Capitalization$11.75 million
P/E RatioN/A
Dividend YieldN/A
Beta2.09

Insider Trades

AzurRx BioPharma (NASDAQ:AZRX) Insider Buying and Selling Activity

Insider Ownership Percentage: 7.20%

AzurRx BioPharma (NASDAQ AZRX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/31/2018Edmund Burke Jr. RossMajor ShareholderBuy23,848$1.12$26,709.76  
12/28/2018Charles J CasamentoDirectorBuy9,000$1.41$12,690.0056,500  
12/28/2018Charles J CasamentoDirectorBuy9,000$1.41$12,690.00  
12/28/2018Johan M SpoorCEOBuy38,583$1.30$50,157.90338,617  
12/28/2018Maged ShenoudaCFOBuy20,000$1.31$26,200.0062,500  
12/28/2018Maged ShenoudaInsiderBuy20,000$1.31$26,200.00  
12/27/2018Edmund Burke Jr. RossMajor ShareholderBuy66,122$1.16$76,701.52  
5/2/2018Edmund Burke Jr. RossMajor ShareholderBuy20,000$2.50$50,000.00  
6/30/2017Pelican Partners LlcMajor ShareholderSell160,000$3.19$510,400.001,787,796  
(Data available from 1/1/2013 forward)
This page was last updated on 10/14/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel